Urteste S.A. (WSE:URT)

Poland flag Poland · Delayed Price · Currency is PLN
82.00
-2.80 (-3.30%)
Apr 30, 2025, 2:43 PM CET
Market Cap 119.54M
Revenue (ttm) n/a
Net Income (ttm) -3.37M
Shares Out 1.41M
EPS (ttm) -2.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16
Average Volume 188
Open 81.40
Previous Close 84.80
Day's Range 81.20 - 82.00
52-Week Range 73.00 - 107.00
Beta 0.17
RSI 46.35
Earnings Date Apr 24, 2025

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 20
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.